Diagnostic Performance of High-Sensitivity Troponin T, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A Assays for Triage of Patients with Acute Myocardial Infarction
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Early diagnosis is the cornerstone of management of acute myocardial infarction (AMI). We aimed to compare the diagnostic accuracy of high-sensitivity troponin T (hs-cTnT) with myeloperoxidase (MPO) and pregnancy-associated plasma protein A (PAPP-A) for early diagnosis of AMI in patients at the time of presentation to the emergency department (ED). Methods: We enrolled 289 patients who presented at the ED of the National Institute of Heart Disease (NIHD) Rawalpindi, Pakistan, within 4 hr of onset of chest pain. Clinical assessment, electrocardiography (ECG), and angiography were carried out. Blood samples were collected at 0, 3, 6, and 12 hr. Analyses of plasma hs-cTnT, MPO, and PAPP-A were carried out using commercial kits. Results: Out of 289 subjects who presented to the ED, we diagnosed 180 patients with coronary heart disease as having AMI (N= 61) and 119 as without AMI (stable coronary artery disease, N=61; unstable angina, N=58). Compared to non-AMI patients, the patients with AMI had significantly higher levels (represented here as median [inter quartile range]) of plasma hs-cTnT (136 [39-370] vs. 12 [7-21] ng/L), MPO (906 [564-1,631] vs. 786 [351-1,299] pmol/L) and PAPP-A (5.78 [2.67-13.4] vs. 2.8 [1.8-4.9] mIU/L). Receiver operator characteristic curves (95% CI) for hs-cTnT (0.952 [0.909-0.978]) were significantly higher (P<0.001) than those for MPO (0.886 [0.830-0.929]) and PAPP-A (0.797 [0.730-0.854]), with AMI sensitivity and specificity percentages of 87% and 98% (hs-cTnT), 82% and 84% (MPO), and 65% and 87% (PAPP-A), respectively. Conclusions: The diagnostic performance of hs-cTnT was superior to that of MPO and PAPP-A for early triage and diagnosis of AMI among patients of coronary heart disease presenting with chest pain to the ED.
Abstract
Background: Early diagnosis is the cornerstone of management of acute myocardial infarction (AMI). We aimed to compare the diagnostic accuracy of high-sensitivity troponin T (hs-cTnT) with myeloperoxidase (MPO) and pregnancy-associated plasma protein A (PAPP-A) for early diagnosis of AMI in patients at the time of presentation to the emergency department (ED). Methods: We enrolled 289 patients who presented at the ED of the National Institute of Heart Disease (NIHD) Rawalpindi, Pakistan, within 4 hr of onset of chest pain. Clinical assessment, electrocardiography (ECG), and angiography were carried out. Blood samples were collected at 0, 3, 6, and 12 hr. Analyses of plasma hs-cTnT, MPO, and PAPP-A were carried out using commercial kits. Results: Out of 289 subjects who presented to the ED, we diagnosed 180 patients with coronary heart disease as having AMI (N= 61) and 119 as without AMI (stable coronary artery disease, N=61; unstable angina, N=58). Compared to non-AMI patients, the patients with AMI had significantly higher levels (represented here as median [inter quartile range]) of plasma hs-cTnT (136 [39-370] vs. 12 [7-21] ng/L), MPO (906 [564-1,631] vs. 786 [351-1,299] pmol/L) and PAPP-A (5.78 [2.67-13.4] vs. 2.8 [1.8-4.9] mIU/L). Receiver operator characteristic curves (95% CI) for hs-cTnT (0.952 [0.909-0.978]) were significantly higher (P<0.001) than those for MPO (0.886 [0.830-0.929]) and PAPP-A (0.797 [0.730-0.854]), with AMI sensitivity and specificity percentages of 87% and 98% (hs-cTnT), 82% and 84% (MPO), and 65% and 87% (PAPP-A), respectively. Conclusions: The diagnostic performance of hs-cTnT was superior to that of MPO and PAPP-A for early triage and diagnosis of AMI among patients of coronary heart disease presenting with chest pain to the ED.
참고문헌 (20)
- Thygesen K, "Universal definition of myocardial infarction", J Am Coll Cardiol, 50, pp.2173~2195 (2007)
- Menown IB, "Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction", Eur Heart J, 21, pp.275~283 (2000)
- Bassand JP, "Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes", Eur Heart J, 28, pp.1598~1660 (2007)
- Reichlin T, "Early diagnosis of myocardial infarction with sensitive cardiac troponin assays", N Engl J Med, 361, pp.858~867 (2009)
- Gururajan P, "Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome", Heart Asia, 1, pp.41~46 (2009)
- Brennan ML, "Prognostic value of myeloperoxidase in patients with chest pain", N Engl J Med, 349, pp.1595~1604 (2003)
- Bayes-Genis A, "Pregnancy-associated plasma protein A as a marker of acute coronary syndromes", N Engl J Med, 345, pp.1022~1029 (2001)
- Lund J, "Circulating pregnancy-associated plasma protein-A predicts outcome in patients with acute coronary syndrome but no Troponin-I elevation", Circulation, 108, pp.1924~1926 (2003)
- Iversen KK, "Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction", Am J Cardiol, 101, pp.1389~1394 (2008)
- McCann CJ, "Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T", Eur Heart J, 29, pp.2843~2850 (2008)
- DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
- Keller T, "Sensitive troponin I assay in early diagnosis of acute myocardial infarction", N Engl J Med, 361, pp.868~877 (2009)
- Achar AS, "Diagnosis of acute coronary syndrome", Am Fam Physician, 72, pp.119~126 (2005)
- Giannitsis E, "High-sensitive cardiac troponin T for early prediction of evolving non-ST- segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission", Clin Chem, 56, pp.642~650 (2010)
- Apple FS, "Assessment of the multiple- biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome", Clin Chem, 55, pp.93~100 (2009)
- Khan SQ, "Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction", Heart, 93, pp.826~831 (2007)
- Mocatta TJ, "Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction", J Am Coll Cardiol, 49, pp.1993~2000 (2007)
- Ndrepepa G, "Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndrome", Eur J Clin Invest, 38, pp.90~96 (2008)
- Esporcatte R, "Impact of myeloperoxidase dosage in acute coronary syndrome", Crit Care, 9(2), pp.30~ (2005)
- Elesber AA, "Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergen-cy department", Int J. Cardiol, 117, pp.365~369 (2007)